Analysts Are Bullish on These Healthcare Stocks: AKAO, BIIBBy Jason Carr
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Achaogen (NASDAQ: AKAO) and Biogen Inc (NASDAQ: BIIB) with bullish sentiments.
Achaogen (NASDAQ: AKAO)
“AKAO moved up Plazomicin (Plz) pivotal Ph3 EPIC cUTI top-line and CARE trial data.”
According to TipRanks.com, Baral is a 4-star analyst with an average return of 5.1% and a 38.7% success rate. Baral covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Protalix Biotherapeutics, and Intra-Cellular Therapies.
Achaogen has an analyst consensus of Moderate Buy.
Biogen Inc (NASDAQ: BIIB)
According to TipRanks.com, Schimmer is ranked 0 out of 5 stars with an average return of -3.7% and a 42.9% success rate. Schimmer covers the Healthcare sector, focusing on stocks such as Ionis Pharmaceuticals Inc, Lion Biotechnologies Inc, and Bellicum Pharmaceuticals.
Currently, the analyst consensus on Biogen Inc is Moderate Buy and the average price target is $341.20, representing a 12.1% upside.
In a report issued on November 25, H.C. Wainwright also reiterated a Buy rating on the stock with a $360 price target.